Thursday, 14 June 2018

A novel research partnership in AI to advance drug discovery, longevity & aging research

(Biogerontology Research Foundation) Thursday, June 14, London, UK: Biogerontology Research Foundation CSO to collaborate with Insilico Medicine and WuXi AppTec on a research study in artificial intelligence for drug discovery. The collaboration will also cover the many novel biological targets implicated in aging and age-related diseases. The Biogerontology Research Foundation salutes its Chief Science Officer, Dr. Alex Zhavoronkov, on the announcement of a research collaboration.

from EurekAlert! - Social and Behavioral Science https://ift.tt/2l82RIf

No comments:

Post a Comment